Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clodagh Murray

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|May 13, 2026
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed AssayScott Strum, Clodagh Murray, Sofia Genta, et al.
NPJ Precision Oncology|February 3, 2026
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patientsSusanne Flach, Christodoulos Pipinikas, Tom Huberty, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael Bryan, et al.
NPJ Precision Oncology|August 22, 2025
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael E Bryan, et al.
NPJ Breast Cancer|July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapyJesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|May 13, 2026
Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed AssayScott Strum, Clodagh Murray, Sofia Genta, et al.
NPJ Precision Oncology|February 3, 2026
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patientsSusanne Flach, Christodoulos Pipinikas, Tom Huberty, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael Bryan, et al.
NPJ Precision Oncology|August 22, 2025
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerDaniel A Ruiz-Torres, Ross D Merkin, Michael E Bryan, et al.
NPJ Breast Cancer|July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapyJesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Pageof 1